Rani Therapeutics appoints Sara Kenkare-Mitra as strategic advisor

se.investing.com (Swedish)

Rani Therapeutics appointed Dr. Sara Kenkare-Mitra as a strategic advisor. Kenkare-Mitra brings nearly 30 years of experience in drug discovery and development, including significant contributions at Genentech. She will advise on platform and clinical strategy. The appointment comes as Rani Therapeutics, which focuses on oral delivery of biologics via its RaniPill technology, navigates its clinical development phase.


With a significance score of 0.9, this news ranks in the top 79% of today's 32905 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Rani Therapeutics appoints Sara Kenkare-Mitra as strategic advisor | News Minimalist